RecruitingNCT02630615
Circulating Tumor Cells (CTC) in Lung Cancer
Sponsor
Shadia Jalal
Enrollment
80 participants
Start Date
Oct 19, 2017
Study Type
OBSERVATIONAL
Conditions
Summary
The primary objective of this study is to establish circulating tumor cell (CTC) derived xenografts and assess the activity of novel DNA repair inhibitors as a function of DNA repair mutations detected in CTC samples (personalize DNA repair therapy).
Eligibility
Min Age: 18 Years
Inclusion Criteria6
- Histologically or cytologically confirmed lung cancer (both non-small cell lung cancer and small cell lung cancer are allowed)
- Stage 4 NSCLC or extensive-stage SCLC
- Newly diagnosed disease with no prior systemic therapy for advanced disease Note: Patients that have received prior adjuvant chemotherapy or prior chemoradiotherapy for earlier stage lung cancer are allowed if treatment was completed ≥3 months.
- Age ≥ 18 years
- Ability to understand and the willingness to sign a written informed consent document
- Inclusion of Women and Minorities Both men and women of all races and ethnic groups are eligible for this study.
Interventions
OTHERBlood draw
Whole blood will be collected using standard phlebotomy procedures
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02630615
Related Trials
To Conduct Multi-omics Integrated Studies in Peripheral Blood, Such as Fragment Omics, Metabolomics and Epigenetics, and Establish Non-invasive Dynamic Follow-up Monitoring Programs During Perioperative and Postoperative Periods (Observational Study)
NCT072919211 location
LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada
NCT071431102 locations
DeniLA: Comprehensive Demographics and Clinical Profile of NSCLC Patients: Analyzing Guideline-Concordant Care in First-line Treatment Patterns
NCT071091547 locations
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
NCT068856971 location
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
NCT015809821 location